Does psychotherapy work? An umbrella review of meta-analyses of randomized controlled trials.
Introduction
Over the past years, many randomized controlled trials (RCTs) have been conducted to assess the effectiveness and/or the efficacy of numerous psychotherapies for various outcomes (1) (2) (3) (4) (5) . Published meta-analyses, a quantitative synthesis of aggregated data, have shown that most of the psychotherapies could be considered effective (1) (2) (3) (4) (5) especially in the case of cognitive behavioural therapy (CBT) (5, 6) . The findings from those meta-analyses are widely used to inform and guide clinical and policy practices. The National Institute for Health and Clinical Excellence (NICE), for example, strongly relies on the conducted meta-analyses to develop recommendations on psychotherapies for various disorders (http://www.nice.org.uk).
However, one may argue that these studies are not free of biases. Facts such as inadequate randomization, small sample sizes, time lag bias on the publication of non-significant reports and inadequate reporting of all available analyses and results are potential sources of biases that raise doubts on the validity and magnitude of reported effect sizes (ES) (7) (8) (9) . Another major concern is that meta-analyses in psychotherapy usually yield moderate-to-large ES compared to lower ES reported in other fields (5, 7, 8) . Emerging empirical meta-research supports that the reported ES might be overestimated due to the existence of various types of systematic biases (8) (9) (10) (11) (12) . For example, we have previously shown that researcher's allegiance bias inflates the treatment effect of psychotherapy by almost 30% (13) and in the vast majority of the articles, this nonfinancial conflict of interest is rarely reported (10) . Empirical studies have also assessed the existence of publication bias in meta-analyses and RCTs for depression (8, 11, 14) . The observed heterogeneity across studies is similarly a fundamental problem which threatens the validity of a conducted meta-analysis (15, 16) . A much debatable question is whether the researchers might use a systematic pattern of practices to produce significant findings (17, 18) . Evidence of excess of statistically significant results (i.e. excess significance bias) has been demonstrated in many medical fields (19) (20) (21) (22) (23) (24) (25) . However, the presence of potential systematic biases in psychotherapy has been assessed only in depression (17) . To the best of our knowledge, there are no systematic efforts to summarize the evidence from the entire psychotherapy field regarding possible heterogeneity, publication bias, small-study effects, selective reporting and excess of significant biases in the published meta-analyses.
Aims of the study
In this project, we performed an umbrella review of the evidence across meta-analyses of RCTs to provide an overview of the range and the validity of the reported effectiveness of psychotherapies. We examined the psychotherapies that provide significant results, and we identified and pinpointed those with convincing evidence. Moreover, we evaluated whether there are hints for biases in this literature favouring statistically significant results.
Methods

Search strategy and eligibility criteria
We did a systematic review in accordance with the Preferred Reporting Items for Systematic Review and Meta-analyses (PRISMA) statement (Appendix S2). We conducted a systematic search from inception to December 2016 in the PubMed, PsycINFO and Cochrane Database of Systematic Reviews (CDSR). To identify all meta-analyses of RCTs regarding psychotherapies applied for broad range of outcomes, we used the following algorithm: (meta-analysis OR systematic review) AND (psychotherapy OR psychoanalysis OR psychological interventions). Only published articles in English were considered. Reference lists of all eligible studies and relevant review articles were also hand-searched to identify additional eligible meta-analyses.
We evaluated meta-analyses that examined any type of psychotherapy treatment vs. any type of control intervention including non-psychotherapeutic treatments (e.g. medication) or other active arms (e.g. other psychotherapy). Meta-analyses of combined treatments (e.g. adding psychotherapy to medication) were also evaluated. We considered eligible meta-analyses of RCTs with at least 10 primary RCTs. From each meta-analysis, we considered all main outcomes as reported by the authors. If the main outcome was not eligible (i.e. <10 studies), we included any secondary outcome that fulfilled our eligibility criteria regarding the number of primary RCTs included. Studied outcomes were categorized as previously proposed in the field of psychotherapy: (26) anxiety-related outcomes, cognitive-related outcomes, depressionrelated outcomes, depression-and anxiety-related outcomes, eating disorders-related outcomes, disease-related physical outcomes (e.g. mortality), disease-specific distress-related outcomes (e.g. depressive symptoms in somatic patients), metabolic disorders-related outcomes (e.g. glycaemic control in diabetes), pain-related outcomes, psychological health-related outcomes (e.g. psychological wellbeing), schizophrenia-related outcomes, smoking-related outcomes (e.g. smoking cessation), substance use-related outcomes, traumarelated outcomes (e.g. severity of symptoms in post-traumatic stress disorder) and various other outcomes (e.g. suicide rates, participants lost to follow-up, sleep efficiency) (26) .
We did not set restrictions regarding the age of participants or special populations (e.g. only inpatients) or format or modality of psychotherapy (e.g. only individual format or only 'face-to-face' treatments). Whenever multiple meta-analyses on the same topic have been performed (i.e. overlapping meta-analyses with the same outcome, psychotherapy type and clinical setting), we assessed only the most recent meta-analysis. Meta-analyses providing only a summary ES, without further data on the primary studies, were not used in the analysis. We excluded narrative reviews, letters to the editor, meta-analyses of non-RCTs and systematic reviews without a quantitative synthesis of data. Two independent investigators (ED and VK) screened the titles, the abstracts of identified articles and the full texts of the potentially eligible articles. If there was disagreement about whether a study was eligible, this was discussed in detail with a third investigator (EE) until consensus was reached.
Data extraction
From each eligible meta-analysis, we recorded the following information: identification number, name of first author, year of publication, type of psychotherapy treatment and control arm, type of outcome, number of primary psychotherapy RCTs, the total number of participants, number of participants in experimental and control arms, the ES of each primary RCT [standardized mean difference (SMD) or odds ratio (OR) or relative risk and their 95% confidence intervals (CI)]. Whenever the data (i.e. ES and CIs) were available only in the form of forest plots, we used the Plot Digitizer tool to accurately extract the ES and its 95% CI.
We used the actual definition adopted by each initial meta-analysis to categorize the type of examined psychotherapy (Appendix S1). Whenever various types of psychotherapies and not a certain type was assessed in the same meta-analyses, we categorized it as 'mixed types of psychotherapies'.
Data extraction was performed independently by two investigators (ED and VK), and in the case of discrepancies, a consensus was reached by a third investigator (EE).
Data synthesis
We applied standardized methods for the umbrella review and state-of-the-art approaches setting stringent criteria to evaluate the findings of the meta-analyses. Specifically, for each meta-analysis, we estimated the summary ES and its 95% CI using random-effects models (27, 28) . We also estimated the 95% prediction interval (PI), for the summary random-effects estimates. PI further accounts for heterogeneity between studies and specify the uncertainty for the effect that would be expected in a new study examining that same research question (28) . Heterogeneity was evaluated with Cochran's Q statistic (statistically significant for P-value < 0.10), and it was quantified with the I 2 metric (29) . I 2 ranges between 0% and 100%, and it is considered low, moderate, large and very large for values <25%, 25-49%, 50-74% and >75% respectively. Egger's test was used to evaluate potential publication and small-study effects biases (30, 31) . In particular, a Pvalue ≤ 0.10 in the regression asymmetry test with more conservative effect in the largest study was considered evidence for small-study effects bias.
To evaluate the excess significance, we applied a test that examines whether the observed number of studies (O) with statistically significant results ('positive' studies) in each meta-analysis is larger than their expected number (E) (20) . This exploratory test is described in detail elsewhere (20) (21) (22) (23) (24) (25) . For each meta-analysis, E is calculated as the sum of the statistical power estimates for each study in the meta-analysis. The power of each study was calculated by an algorithm using a non-central t distribution (32) . The estimated power depends on the plausible ES. As the true ES for any meta-analysis is unknown, we assumed that the most plausible effect is given by the largest study. Excess significance for each meta-analysis was claimed at P-value ≤ 0.10 level (20, 24) . We also performed subgroup analyses of the excess significance test by calculating the ratio of O over E in all meta-analyses and across predefined subgroups of meta-analyses such as (i) significant vs. non-significant results (by randomeffects), (ii) presence vs. absence of heterogeneity, presence vs. absence of small-study effects bias, P-value distributions, presence of sponsorship vs. no sponsorship), total number of participants, psychotherapy type and age of participants (i.e. adults and older adults vs. children and adolescents vs. any age).
We assessed the credibility of the evidence using several criteria (33) . Specifically, meta-analyses had the strongest validity and were not suggestive of bias (Class I) whenever they met the following criteria: had P-value < 10 À6 based on randomeffects meta-analysis; had >1000 participants; had low or moderate between-study heterogeneity (I 2 < 50%); had 95% PI that excluded the null value; and had no evidence of small-study effects and excess significance. Highly suggestive evidence (Class II) required >1000 participants, highly significant summary associations (P-value < 10
À6 by random-effects) and 95% PI not including the null value. Suggestive evidence (Class III) criteria required only >1000 participants and Pvalue ≤ 0.001 by random-effects. Weak evidence (Class IV) criteria required only P-value ≤ 0.05 (33) .
The statistical analysis and the power calculations were performed using STATA version 12.0 (STATA Corp, College Station, TX, USA). P-values are two tailed.
Results
Search results
We examined 37 662 titles from PubMed, PsycINFO and the CDSR. We scrutinized the full text of 1899 retrieved articles and 1390 were excluded because they were not fulfilling our inclusion criteria ( Fig. 1) , whereas 509 studies were deemed eligible for further evaluation. An additional 336 studies were excluded for various reasons ( Fig. 1) , leaving a total sample of 173 eligible articles that assessed 247 meta-analyses/comparisons (Supporting information). Of note, 130 of the 173 studies assessed only one main outcome whereas 43 assessed more than one main outcome (range: 2-5).
The 247 unique meta-analyses synthesized data from 5157 primary RCTs. Each meta-analysis included a median of 16 studies [interquartile range (IQR): 12-24] with a median number of participants equal to 1358 (IQR: 870-2273). The total number of participants was >1000 in 169 of 247 meta-analyses. Most meta-analyses (83%) measured continuous ESs and the most studied outcomes were depression-related outcomes (n = 65), anxiety-related outcomes (n = 37), disease-related physical outcomes (n = 20), disease-specific distress-related outcomes (n = 27), pain-related outcomes (n = 14), trauma-related outcomes (n = 18) and various other outcomes (n = 20). The rest of the examined outcomes (n = 46) are summarized in Table 1 . The type of psychotherapy mainly examined was CBT (n = 84) and mixed types of psychotherapies including CBT (n = 107). Fifty-six meta-analyses examined various other types of psychotherapies ( Table 1 ). The comparator was active control (e.g. different variant of the same intervention, different drug or a different type of therapy) in 41 meta-analyses, inactive control [e.g. placebo, no treatment, standard care (TAU) or a waiting list control] in 136 meta-analyses and both active and inactive control in 70 meta-analyses (Table 1) . Table S1 provides information for all 247 metaanalyses in the 173 eligible studies. Of the 247 meta-analyses, 199 (81%) reported a nominally (P ≤ 0.05) statistically significant summary effect using random-effects models, of which 196 (79%) favoured the experimental psychotherapy treatment whereas only three favoured the control group. In 178 (72%) meta-analyses, the estimates of the PIs included the null value (Table 1 ). In 118 (48%) meta-analyses, the ES of the largest study in each meta-analysis had a nominally statistically significant result, as described in Tables 1 and S2 . The ES of the largest study in each meta-analysis was more conservative than the random-effects summary estimate in 141 (57%) meta-analyses. In 49 of 118 (42%) meta-analyses, the ES of the largest study was both nominally significant and more conservative than the random-effects summary estimate (Table S1 ).
Summary ESs
Between-study heterogeneity and small-study effects Statistically significant heterogeneity (P ≤ 0.10) was observed in 168 (68%) meta-analyses (Table 1) . Specifically, 82 meta-analyses (33%) had large heterogeneity (I 2 > 50%) and 48 (20%) had very large heterogeneity (I 2 > 75%). The highest proportion of very large and large significant heterogeneity was observed in meta-analyses of other types of psychotherapies (n = 36; 64%). Moderate heterogeneity was found in 55 metaanalyses (22%), whereas 62 meta-analyses (25%) had low heterogeneity (Table S1) .
Asymmetry tests revealed evidence of publication bias in 108 (44%) meta-analyses. Evidence for significant small-study effects using both criteria, that is P-value for Egger's test ≤0.10, and largest study with a more conservative ES than randomeffects summary estimate was found in 72 metaanalyses (29%) ( Table 1) . This pertained to CBT (n = 25), mixed types of psychotherapies (n = 33) and other types of psychotherapies (n = 14).
Additional details per type of psychotherapy and outcome are presented in Table S1 .
Excess significance in meta-analyses of psychotherapy
When the plausible effect was assumed to be that of the ES of the largest study in each meta-analysis, there was evidence (P ≤ 0.10) of excess significance bias in 95 (39%) of 247 meta-analyses (Table 1) . These pertained to CBT (n = 28), mixed types of psychotherapies (n = 45) and other types of psychotherapies (n = 22). Details per type of psychotherapy and outcome are also summarized in Table S3 . Table 2 shows combined data from all the metaanalyses and according to different subgroups. Among 5157 RCTs included in 247 meta-analyses, 2066 (40%) had nominally statistically significant results, whereas the expected number was 1683 (32%). The difference between the observed and expected positive findings was significant (P < 0.001). The excess of significant findings for the meta-analyses was documented across almost all examined subgroups. The highest ratio of excess significant bias (as characterized by the ratio of O over E) was found in meta-analyses with smallstudy effects bias (O/E = 1.85) and the lowest those regarding CBT (O/E = 1.13) ( Table 2) . 258 (5) 1347 (26) 37 (0.7)
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P-value distributions for all meta-analyses of psychotherapy
Of the 199 meta-analyses with a nominally (P ≤ 0.05) statistically significant summary effect per random-effects synthesis, 91 (46%) had a Pvalue < 10
À6
, 69 (35%) had a P-value > 10 À6 but ≤0.001 and 39 (19%) had a P-value between 0.002 and 0.05. The highest proportion of meta-analyses at the P-value < 10 À6 level was observed in metaanalyses of CBT (40%; n = 36) and in mixed types of psychotherapy (46%; n = 42). Details per outcome are also presented in Table S1 .
Psychotherapeutic treatments with strong evidence of effectiveness
Of the 247 meta-analyses, only 16 (7%) had convincing evidence (Class I) criteria in favour of the psychotherapy treatment; nominally statistically significant summary treatment effects per randomeffects meta-analysis at P-value < 10 À6 level had a total sample size of over 1000 participants, low or moderate heterogeneity (I 2 < 50%), had a 95% PI that excluded the null value, had no evidence of small-study effects (P-value for Egger's test ≤0.10, and largest study with a more conservative ES than random-effects summary ES), and no evidence for excess significance (Table 3) . These pertained to meditation therapy and CBT for anxiety-related outcomes (n = 3), mixed types of psychotherapy (combined with pharmacotherapy) and CBT for depression-related outcomes (n = 6), CBT for tinnitus distress (n = 1), mixed types of psychotherapy for mental health and daily functioning in irritable bowel syndrome (n = 2), cognitive remediation for schizophrenia (n = 1), CBT and counselling for smoking-related outcomes (n = 2), and CBT for depression in insomnia (n = 1). Of note, we found one additional meta-analysis with convincing evidence that was in favour of the comparator (i.e. combination of psychotherapy with medication). Highly suggestive evidence criteria CBT, cognitive behavioural therapy; RCTs, randomized controlled trials. *Expected number of statistically significant studies using the effect of the most precise study of each meta-analysis as the plausible effect size (ES); NP = not pertinent, because the estimated E (Expected) is larger than the O (Observed), and there is no evidence of excess statistical significance based on the assumption made for the plausible ES. †Both criteria for existence of small-study effects fulfilled (P-value for Egger's test ≤0.10, and largest study with a smaller (more conservative) ES than random-effects summary ES).
(Class II) were met by 20 (8%) meta-analyses. The most common psychotherapies in those meta-analyses were mixed type of psychotherapies (n = 12) and CBT (n = 7). Effects of psychotherapies were supported by suggestive evidence (Class III) were found for 76 (31%) meta-analyses, whereas weak evidence (Class IV) was observed in 86 (35%) meta-analyses. Finally, 48 (19%) of 247 metaanalyses had non-significant treatment effects estimates. These results are presented in Tables S4-S7 .
Discussion
We performed an umbrella review evaluating the current evidence of psychotherapy effectiveness for a wide range of outcomes in 247 meta-analyses. An impressive 80% of the meta-analyses report a nominally (P ≤ 0.05) statistically significant random-effects summary estimate that favours the experimental psychotherapy treatment. However, our results indicate that the effectiveness of psychotherapy is often exaggerated. Only 16 of the assessed meta-analyses found to provide convincing evidence indicating that several published meta-analyses in the field could be susceptible to biases. The most robust evidence was found for meta-analyses evaluating meditation therapy and CBT for anxiety symptoms, combination of mixed types of psychotherapy and CBT for depressive symptoms, CBT for tinnitus distress, mixed types of psychotherapies for mental health symptoms and daily functioning in irritable bowel syndrome, cognitive remediation therapy for cognitive functioning in schizophrenia, CBT and counselling for smoking cessation as well as computerized CBT for depression in insomniac patients. Hence, our findings suggest that the largest body of the 
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Excluding the null value I 2 < 50% Neither IBS, irritable bowel syndrome; CI, confidence intervals; PT, psychotherapy; CBT, cognitive behavioural therapy; CR, cognitive remediation; WL, waiting list; PHA, pharmacotherapy; TAU, treatment as usual; SH, self-help; OT, other treatment; OPT, other psychotherapy; PL, placebo; C, control (mixed group active and inactive). Convincing evidence (Class I) criteria: significant summary effect sizes (P < 10
) per random-effects calculations; >1000 participants, not large heterogeneity (I 2 < 50%); prediction intervals not including the null hypothesis; no evidence of small-study effects and no evidence for excess significance bias.
published evidence is eventually ambiguous in the present field, including well-established treatments such as CBT. We observed that 2/3 of the meta-analyses had statistically significant heterogeneity, and more than half had I 2 > 50%. Even though the observed heterogeneity may reflect to true between-study differences and can be handled in several ways (15, 16, 29) , the amount of heterogeneity observed in this systematic review was larger than expected if we take into consideration that we assessed metaanalyses of RCTs that are less prone to biases compared to other study designs (34) . The observed large heterogeneity across studies might further be attributed to the fact that many RCTs entail clinically heterogeneous subpopulations (16) . On the other hand, psychotherapies are complex interventions (35) and, in contrast to pharmacological interventions, are focused on the whole person rather than a biochemical process, implying complexities with regard to the definition of examined outcomes and the characteristics of the interventions per se (35, 36) .
We also found that a noteworthy number of meta-analyses suffer from small-study effects bias which can be considered a form of publication bias. This has been observed in other studies that have shown that the results of up to 25% of the psychotherapy RCTs have never been published (11, 14) . Small-study effects are not unusual in the medical field (30, 37) . A combination of factors such as inadequate methodological quality of small trials along with publication and other reporting biases or true clinical heterogeneity (i.e. high risk patients with short-term follow-up periods) can result in small-study effects (38) . Excess of significance bias has also been observed in several medical fields (21) (22) (23) (24) (25) , and our results indicate the same for RCTs in psychotherapy. We found that 40% of all included studies had nominally statistically significant results while the expected number was 31%. Apparently, our results are in agreement with the work of Flint al. (17) who found a remarkable excess significant bias in psychotherapy RCTs focus on depression. Moreover, the differences in the effects sizes across studies could be merely a mark of vibration effects when various analytical approaches were implemented (19) .
Another important finding of the present study was that the most extreme ratios of excess significant bias (as characterized by the ratio of O over E) were found in meta-analyses with small-study effects bias (O/E = 1.85) and those applied in children and adolescents (O/E = 2.62). In the first case, this result may be explained by the fact that a smaller study is more susceptible in controlling data, analysis and reporting compared to a welldesigned, larger study. Indeed, one-third of the meta-analyses in our study had <1000 participants. In the second case, it could conceivably be hypothesized that studies conducted in children and adolescents are easier to raise the expectations of the participants, which results in more positive effects (5) . However, further research on this topic needs to be undertaken before more definite conclusions can be drawn.
Our findings indicate that studies with negative or null outcomes on the field often remain unpublished or their results are selectively reported (17, (39) (40) (41) . A recent systematic review concluded that many psychotherapy RCTs are incorrectly registered and reported (41) . Comparable results have also been drawn from the literature on psychotherapy for depression (8, 11, 14, 17) as well as in other medical fields (23-25, 33, 39) . It is also possible that these conditions are more likely to occur in less studied types of psychotherapy treatments in which negative results or null findings are more difficult to get published (14, 17, 39, 40) . For example, the ratio of excess of significant findings was much higher in mixed and in other types of psychotherapeutic treatments compared to CBT alone (O/E = 1.31 vs. O/E = 1.24 vs. O/E = 1.13, respectively) which is by far the most studied type of psychotherapy (2) . Possible differences between the investigated and reported outcomes in the protocol and the published studies may act as an additional threat on the validity of the meta-analytic results (39) . This could also imply that the statistical significance, the perceived importance and the direction of study results may well account for the variations in the publication status of psychotherapy studies. It has been found that these factors are strongly associated with the publication bias with an odds ratio equal to 3.90 (40) . Our results revealed that 65% of the published meta-analyses in psychotherapy field reached a P-value below 0.001. This is in accordance with a previous report who found that the number of studies in psychology with a P-value just below 0.05 was much higher than expected based by chance (42) . In addition to that, a recent study found that the odds of reporting positive results in published studies were five times higher in psychology and psychiatry compared to the other fields (43) .
One caveat of our study is that we included only studies used in published meta-analyses and, therefore, we may have missed evidence derived from single RCTs with large sample sizes. Moreover, we included meta-analysis that contained ≥10 studies and therefore, we may have missed any meta-analyses that included a smaller number of RCTs but accumulated a larger total sample size.
One of the issues that emerge from our findings is the necessity of publishing null and/or negative results. All new RCTs in psychotherapy should be correctly registered and their statistical methods and analysis should be clearly reported before the implementation of a study to eliminate selective analysis results and selective reporting biases (19, 24) , especially when there is evidence for nonfinancial conflict of interests (10, 13) . Previous clinical trials could also be registered including those with negative findings, following the guidelines on, for example ClinicalTrials.gov. Our results also highlight the necessity of conducting large psychotherapy RCTs. This study further suggests that the dissemination of evidence-based psychotherapy treatments will be achieved through an array of efforts to minimize the potential influence of those biases when researchers conduct a meta-analysis and interpret their results. These efforts should include a thorough and comprehensive search strategy, selection of published and unpublished findings, inclusion of non-significant effects and if possible, adjustment for publication bias. Data from additional studies and investigation of sources of heterogeneity are needed for a better evaluation of the pattern of psychotherapy effectiveness. To end with, health policymakers and clinical experts should be aware of possible biases in published meta-analyses and they should scrutinize all the available evidence to increase the validity of their guidance. However, the uncertainty of the reported results observed here is further complicated by the fact that the nature of psychotherapy itself makes it difficult to establish what kind of evidence is actually needed to offer support for the effectiveness of psychotherapy (5).
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